Literature DB >> 2668303

Association of type 3 protein kinase C with focal contacts in rat embryo fibroblasts.

S Jaken1, K Leach, T Klauck.   

Abstract

We have used immunocytofluorescence techniques to determine the subcellular distribution of the Ca2+, phospholipid-dependent protein kinase, protein kinase C (PKC). Using monoclonal antibodies that are specific for Type 3 (alpha) PKC, we have determined that there are least two pools of PKC in normal rat embryo fibroblasts (REF52 cells): diffuse cytoplasmic and fiber-associated. Extraction with chelators and detergent before fixing and staining removes the cytoplasmic PKC. The fiber-associated staining remains in these cytoskeleton preparations. The cytoskeleton Type 3 PKC staining closely resembles that of the focal contact protein vinculin and colocalizes with another focal contact protein, talin. Cytochalasin, but not colchicine, coordinately disrupts the staining pattern of vinculin and PKC. Activation of PKC by treatment with phorbol esters causes depolymerization of microfilaments and reorganization of vinculin staining. We propose that Type 3 PKC is a modulatory component of the focal contact and has a primary role in regulation of the association of microfilament bundles with the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668303      PMCID: PMC2115725          DOI: 10.1083/jcb.109.2.697

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  35 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Phorbol diester receptor copurifies with protein kinase C.

Authors:  J E Niedel; L J Kuhn; G R Vandenbark
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

3.  Immunofluorescence and immunocytochemical procedures with affinity purified antibodies: tubulin-containing structures.

Authors:  M Osborn; K Weber
Journal:  Methods Cell Biol       Date:  1982       Impact factor: 1.441

4.  Vinculin phosphorylation in response to calcium and phorbol esters in intact cells.

Authors:  D K Werth; I Pastan
Journal:  J Biol Chem       Date:  1984-04-25       Impact factor: 5.157

5.  Adhesion plaques of Rous sarcoma virus-transformed cells contain the src gene product.

Authors:  L R Rohrschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

6.  Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane.

Authors:  A S Kraft; W B Anderson
Journal:  Nature       Date:  1983 Feb 17-23       Impact factor: 49.962

7.  Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters.

Authors:  M Castagna; Y Takai; K Kaibuchi; K Sano; U Kikkawa; Y Nishizuka
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

8.  Ca2+-activated, phospholipid-dependent protein kinase catalyzes the phosphorylation of actin-binding proteins.

Authors:  S Kawamoto; H Hidaka
Journal:  Biochem Biophys Res Commun       Date:  1984-02-14       Impact factor: 3.575

9.  A new protein of adhesion plaques and ruffling membranes.

Authors:  K Burridge; L Connell
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

10.  Type 3 protein kinase C localization to the nuclear envelope of phorbol ester-treated NIH 3T3 cells.

Authors:  K L Leach; E A Powers; V A Ruff; S Jaken; S Kaufmann
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

View more
  72 in total

1.  beta1 integrins regulate keratinocyte adhesion and differentiation by distinct mechanisms.

Authors:  L Levy; S Broad; D Diekmann; R D Evans; F M Watt
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

2.  Tyrosine phosphorylation of focal adhesion kinase and paxillin regulates the signaling mechanism of the rapid nongenomic action of dexamethasone on actin cytoskeleton.

Authors:  S B Koukouritaki; A Gravanis; C Stournaras
Journal:  Mol Med       Date:  1999-11       Impact factor: 6.354

3.  A protein kinase C isozyme is translocated to cytoskeletal elements on activation.

Authors:  D Mochly-Rosen; C J Henrich; L Cheever; H Khaner; P C Simpson
Journal:  Cell Regul       Date:  1990-08

4.  Identification of intracellular receptor proteins for activated protein kinase C.

Authors:  D Mochly-Rosen; H Khaner; J Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

5.  Protein kinase C epsilon is localized to the Golgi via its zinc-finger domain and modulates Golgi function.

Authors:  C Lehel; Z Olah; G Jakab; W B Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

6.  Selective loss of substrate recognition induced by the tumour-associated D294G point mutation in protein kinase Calpha.

Authors:  C Prévostel; V Alvaro; A Vallentin; A Martin; S Jaken; D Joubert
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

7.  Characterization of an invasive phenotype associated with enteroaggregative Escherichia coli.

Authors:  P Benjamin; M Federman; C A Wanke
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase.

Authors:  J D Hildebrand; J M Taylor; J T Parsons
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

9.  Evidence for a role of conventional protein kinase-C alpha in the control of homotypic contacts and cell scattering of HT-29 human intestinal cells.

Authors:  M D Llosas; E Batlle; O Coll; A Skoudy; M Fabre; A García de Herreros
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

10.  Characterization of site-specific mutants altered at protein kinase C beta 1 isozyme autophosphorylation sites.

Authors:  J Zhang; L Wang; J Petrin; W R Bishop; R W Bond
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.